Therapeutic strategies demonstrating efficacy in tauopathy mouse models include antibody targeting of specific tau species, antisense-mediated inhibition of tau expression, and small molecule-mediated inhibition of specific tau kinases, acetyltransferases, proteases or aggregation [59]. This evidence concerns the gene MAPT and tauopathy.